Emmanuel S Antonarakis

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 27

Top Topics

Replacement Therapy

Radical Prostatectomy

Renal Cell Carcinoma

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Alan H Bryce, E David Crawford, Neeraj Agarwal, Maha H Hussain, Himisha Beltran, Matthew R Cooperberg, Daniel P Petrylak, Neal Shore, Daniel E Spratt, Scott T Tagawa, Emmanuel S Antonarakis, Ana M Aparicio, Andrew J Armstrong, Thomas P Boike, Jeremie Calais, Michael A Carducci, Brian F Chapin, Michael S Cookson, John W Davis, Tanya Dorff, Scott E Eggener, Felix Y Feng, Martin Gleave, Celestia Higano, Andrei Iagaru, Alicia K Morgans, Michael J Morris, Katie S Murray, Wendy Poage, Matthew B Rettig, Oliver Sartor, Howard I Scher, Paul Sieber, Eric Small, Sandy Srinivas, Evan Y Yu, Tian Zhang, Phillip J Koo
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2. JU open plus 2 (4) (2024)
David A Potter, Zhijun Guo, Jianxun Lei, Emmanuel S Antonarakis
Cooling inflammation while potentiating immune checkpoint inhibition: Enhancing the benefit-risk ratio of immuno-oncology therapy. Proceedings of the National Academy of Sciences of the United States of America 121 (9) (2024)
E David Crawford, Alan H Bryce, Maha H Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R Cooperberg, Daniel P Petrylak, Neal Shore, Daniel E Spratt, Scott T Tagawa, Emmanuel S Antonarakis, Ana M Aparicio, Andrew J Armstrong, Thomas P Boike, Jeremie Calais, Michael A Carducci, Brian F Chapin, Michael S Cookson, John W Davis, Tanya Dorff, Scott E Eggener, Felix Y Feng, Martin Gleave, Celestia Higano, Andrei Iagaru, Alicia K Morgans, Michael Morris, Katie S Murray, Wendy Poage, Matthew B Rettig, Oliver Sartor, Howard I Scher, Paul Sieber, Eric Small, Sandy Srinivas, Evan Y Yu, Tian Zhang, Phillip J Koo
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1. JU open plus 2 (4) (2024)
Samuel A Kareff, Asaad Trabolsi, Harris B Krause, Timothy Samec, Andrew Elliott, Estelamari Rodriguez, Coral Olazagasti, Dionysios C Watson, Matias A Bustos, Dave S B Hoon, Stephanie L Graff, Emmanuel S Antonarakis, Sanjay Goel, George Sledge, Gilberto Lopes
The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors. Cancers 16 (8) (2024)
Catherine Handy Marshall, Lukasz P Gondek, Violet Daniels, Changxue Lu, Sergiu Pasca, Jiajun Xie, Mark C Markowski, Channing J Paller, Laura A Sena, Samuel R Denmeade, Jun Luo, Emmanuel S Antonarakis
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer. The Prostate 84 (10) (2024)
David A Potter, Zhijun Guo, Jianxun Lei, Emmanuel S Antonarakis
Cooling inflammation while potentiating immune checkpoint inhibition: Enhancing the benefit-risk ratio of immuno-oncology therapy. Proceedings of the National Academy of Sciences of the United States of America 121 (9) (2024)
Samuel A Kareff, Asaad Trabolsi, Harris B Krause, Timothy Samec, Andrew Elliott, Estelamari Rodriguez, Coral Olazagasti, Dionysios C Watson, Matias A Bustos, Dave S B Hoon, Stephanie L Graff, Emmanuel S Antonarakis, Sanjay Goel, George Sledge, Gilberto Lopes
The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors. Cancers 16 (8) (2024)
Eric Ovruchesky, Elizabeth Pan, Melis Guer, Andrew Elliott, Shankar Siva, Praful Ravi, Bradley Alexander McGregor, Aditya Bagrodia, Ithaar Derweesh, Pedro C Barata, Elisabeth I Heath, Emmanuel S Antonarakis, Sourat Darabi, Dave S B Hoon, Amir Mortazavi, Toni K Choueiri, Chadi Nabhan, Shuanzeng Wei, Rana R McKay
Characterization of FOLH1 Expression in Renal Cell Carcinoma. Cancers 16 (10) (2024)
David A Potter, Zhijun Guo, Jianxun Lei, Emmanuel S Antonarakis
Cooling inflammation while potentiating immune checkpoint inhibition: Enhancing the benefit-risk ratio of immuno-oncology therapy. Proceedings of the National Academy of Sciences of the United States of America 121 (9) (2024)
E David Crawford, Alan H Bryce, Maha H Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R Cooperberg, Daniel P Petrylak, Neal Shore, Daniel E Spratt, Scott T Tagawa, Emmanuel S Antonarakis, Ana M Aparicio, Andrew J Armstrong, Thomas P Boike, Jeremie Calais, Michael A Carducci, Brian F Chapin, Michael S Cookson, John W Davis, Tanya Dorff, Scott E Eggener, Felix Y Feng, Martin Gleave, Celestia Higano, Andrei Iagaru, Alicia K Morgans, Michael Morris, Katie S Murray, Wendy Poage, Matthew B Rettig, Oliver Sartor, Howard I Scher, Paul Sieber, Eric Small, Sandy Srinivas, Evan Y Yu, Tian Zhang, Phillip J Koo
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1. JU open plus 2 (4) (2024)
Catherine Handy Marshall, Lukasz P Gondek, Violet Daniels, Changxue Lu, Sergiu Pasca, Jiajun Xie, Mark C Markowski, Channing J Paller, Laura A Sena, Samuel R Denmeade, Jun Luo, Emmanuel S Antonarakis
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer. The Prostate 84 (10) (2024)
Eric Ovruchesky, Elizabeth Pan, Melis Guer, Andrew Elliott, Shankar Siva, Praful Ravi, Bradley Alexander McGregor, Aditya Bagrodia, Ithaar Derweesh, Pedro C Barata, Elisabeth I Heath, Emmanuel S Antonarakis, Sourat Darabi, Dave S B Hoon, Amir Mortazavi, Toni K Choueiri, Chadi Nabhan, Shuanzeng Wei, Rana R McKay
Characterization of FOLH1 Expression in Renal Cell Carcinoma. Cancers 16 (10) (2024)
E David Crawford, Alan H Bryce, Maha H Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R Cooperberg, Daniel P Petrylak, Neal Shore, Daniel E Spratt, Scott T Tagawa, Emmanuel S Antonarakis, Ana M Aparicio, Andrew J Armstrong, Thomas P Boike, Jeremie Calais, Michael A Carducci, Brian F Chapin, Michael S Cookson, John W Davis, Tanya Dorff, Scott E Eggener, Felix Y Feng, Martin Gleave, Celestia Higano, Andrei Iagaru, Alicia K Morgans, Michael Morris, Katie S Murray, Wendy Poage, Matthew B Rettig, Oliver Sartor, Howard I Scher, Paul Sieber, Eric Small, Sandy Srinivas, Evan Y Yu, Tian Zhang, Phillip J Koo
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1. JU open plus 2 (4) (2024)
Dan Morgenstern-Kaplan, Samuel A Kareff, Asaad Trabolsi, Estelamari Rodriguez, Harris B Krause, Jennifer R Ribeiro, Heng Tan, Emmanuel S Antonarakis, Emil Lou, Misako Nagasaka, Sandra Algaze, Heinz-Josef Lenz, Stephen V Liu, Balazs Halmos, Dave S B Hoon, Peter Andreas Seeber, Patrick C Ma, Wafik S El-Deiry, Ari M VanderWalde, Gilberto de Lima Lopes
Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors. The oncologist (2024)
David A Potter, Zhijun Guo, Jianxun Lei, Emmanuel S Antonarakis
Cooling inflammation while potentiating immune checkpoint inhibition: Enhancing the benefit-risk ratio of immuno-oncology therapy. Proceedings of the National Academy of Sciences of the United States of America 121 (9) (2024)
Alan H Bryce, E David Crawford, Neeraj Agarwal, Maha H Hussain, Himisha Beltran, Matthew R Cooperberg, Daniel P Petrylak, Neal Shore, Daniel E Spratt, Scott T Tagawa, Emmanuel S Antonarakis, Ana M Aparicio, Andrew J Armstrong, Thomas P Boike, Jeremie Calais, Michael A Carducci, Brian F Chapin, Michael S Cookson, John W Davis, Tanya Dorff, Scott E Eggener, Felix Y Feng, Martin Gleave, Celestia Higano, Andrei Iagaru, Alicia K Morgans, Michael J Morris, Katie S Murray, Wendy Poage, Matthew B Rettig, Oliver Sartor, Howard I Scher, Paul Sieber, Eric Small, Sandy Srinivas, Evan Y Yu, Tian Zhang, Phillip J Koo
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2. JU open plus 2 (4) (2024)
Samuel A Kareff, Asaad Trabolsi, Harris B Krause, Timothy Samec, Andrew Elliott, Estelamari Rodriguez, Coral Olazagasti, Dionysios C Watson, Matias A Bustos, Dave S B Hoon, Stephanie L Graff, Emmanuel S Antonarakis, Sanjay Goel, George Sledge, Gilberto Lopes
The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors. Cancers 16 (8) (2024)
Alan H Bryce, E David Crawford, Neeraj Agarwal, Maha H Hussain, Himisha Beltran, Matthew R Cooperberg, Daniel P Petrylak, Neal Shore, Daniel E Spratt, Scott T Tagawa, Emmanuel S Antonarakis, Ana M Aparicio, Andrew J Armstrong, Thomas P Boike, Jeremie Calais, Michael A Carducci, Brian F Chapin, Michael S Cookson, John W Davis, Tanya Dorff, Scott E Eggener, Felix Y Feng, Martin Gleave, Celestia Higano, Andrei Iagaru, Alicia K Morgans, Michael J Morris, Katie S Murray, Wendy Poage, Matthew B Rettig, Oliver Sartor, Howard I Scher, Paul Sieber, Eric Small, Sandy Srinivas, Evan Y Yu, Tian Zhang, Phillip J Koo
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2. JU open plus 2 (4) (2024)
David A Potter, Zhijun Guo, Jianxun Lei, Emmanuel S Antonarakis
Cooling inflammation while potentiating immune checkpoint inhibition: Enhancing the benefit-risk ratio of immuno-oncology therapy. Proceedings of the National Academy of Sciences of the United States of America 121 (9) (2024)
Catherine Handy Marshall, Lukasz P Gondek, Violet Daniels, Changxue Lu, Sergiu Pasca, Jiajun Xie, Mark C Markowski, Channing J Paller, Laura A Sena, Samuel R Denmeade, Jun Luo, Emmanuel S Antonarakis
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer. The Prostate (2024)
Adel Mandl, Mark C Markowski, Michael A Carducci, Emmanuel S Antonarakis
Role of bromodomain and extraterminal (BET) proteins in prostate cancer. Expert opinion on investigational drugs (2023)
Sree M Lanka, Nicholas A Zorko, Emmanuel S Antonarakis, Pedro C Barata
Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond. Current oncology (Toronto, Ont.) 30 (4) (2023)
Emmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, Sang Joon Shin, Jae Lyun Lee, Niven Mehra, Ray S McDermott, Núria Sala-Gonzalez, Peter C Fong, Richard Greil, Margitta Retz, Juan Pablo Sade, Patricio Yanez, Eric Yi-Hsiu Huang, Stephen D Begbie, Rustem Airatovich Gafanov, Maria De Santis, Eli Rosenbaum, Michael P Kolinsky, Felipe Rey, Kun-Yuan Chiu, Guilhem Roubaud, Gero Kramer, Makoto Sumitomo, Francesco Massari, Hiroyoshi Suzuki, Ping Qiu, Jinchun Zhang, Jeri Kim, Christian H Poehlein, Evan Y Yu
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Emmanuel S Antonarakis, Wassim Abida
Combining Poly(ADP)-Ribose Polymerase Inhibitors With Abiraterone in Castration-Resistant Prostate Cancer: Is Biomarker Testing Necessary? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sree M Lanka, Nicholas A Zorko, Emmanuel S Antonarakis, Pedro C Barata
Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond. Current oncology (Toronto, Ont.) 30 (4) (2023)
Sree M Lanka, Nicholas A Zorko, Emmanuel S Antonarakis, Pedro C Barata
Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond. Current oncology (Toronto, Ont.) 30 (4) (2023)
Sree M Lanka, Nicholas A Zorko, Emmanuel S Antonarakis, Pedro C Barata
Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond. Current oncology (Toronto, Ont.) 30 (4) (2023)